Home Visioneering Technologies Inc.: Redefining Vision NaturalVue® Multifocal Wins The Contact Lens Award for 2024

NaturalVue® Multifocal Wins The Contact Lens Award for 2024

The Contact Lens Award for NaturalVue featuring Maxine Green and Nick Atkins of Positive Impact, VTI’s Authorized Distributor In the United Kingdom

Visioneering Technologies, Inc. announces that NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, in partnership with its Authorized Distributor Positive Impact, has won The Contact Lens Award at the prestigious Optician Awards.

The Optician Awards celebrates excellence within the UK optical industry. With a legacy spanning over 30 years, these awards are among the most esteemed recognitions in British optics. The winners were unveiled on November 22 in London.

The Contact Lens Award honors products and companies that have made a significant impact in the contact lens market over the past year. Judged by a panel of UK-based contact lens specialists, this category evaluates each nominee based on their innovation, contribution to market growth, and success in real-world practices.

The win recognizes the unique role that NaturalVue® Multifocal lenses have played in advancing contact lens technology, along with its commitment to supporting eye care professionals and providing products that exceed customer expectations. The release of the Year 1 results from the 3-year PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue® Multifocal Contact Lens) was instrumental in this nomination, showcasing
our commitment to myopia management and improving the quality of life of patients. Dr. Juan Carlos Aragón, CEO and Executive Director of VTI, noted, “A special thanks to Positive Impact who put together an impressive and comprehensive submission for the award that among the highlights from our PROTECT study also included valuable feedback from NaturalVue fitters and patient experiences with the lenses. We are deeply
honored to receive this coveted award and thank our partners for being part of our journey to bring innovative vision solutions to life.”

The PROTECT study, a three-year, randomized, double-masked, controlled clinical trial, evaluates the safety and efficacy of NaturalVue Multifocal lenses for managing myopia progression in children—a crucial area in pediatric eye care.

MKT-VTI-PR89

Featured image: NaturalVue Multifocal – The Contact Lens Award 2024 and the Positive Impact Team, Courtesy of VTI.

 

Read other stories from Visioneering Technologies Inc. here

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

- Advertisment -

Most Popular

Amy Gallant Sullivan and Dr. Melissa Barnett: How Old Is That Mascara?

Amy Gallant Sullivan, creator of the Eyes Are the Story optocosmetics brand and executive director at the Tear Film & Ocular Surface Society (TFOS), and Melissa Barnett,...

Eye-Safe Makeup: What Clinicians and Patients Need to Know

The intersection of beauty and eye health was the focus of a recent WO Voices podcast featuring Amy Gallant Sullivan, creator of the Eyes...

NaturalVue® Multifocal Wins The Contact Lens Award for 2024

Visioneering Technologies, Inc. announces that NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, in partnership with its Authorized Distributor Positive Impact, has won The...

Empowering Book for Women and Girls by Dr. Kara Foster

Kara Foster, OD, of Apex, North Carolina, wants to share her message of empowerment and girl-power cool in her book of poems and fun...